TRCT
NMRD

Tower Research Capital (TRC)’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Tower Research Capital (TRC)’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,872
Closed -$2.6K – 6345
2023
Q4 		$2.6K Sell
11,872
-68
-0.6% -$16 ﹤0.01% 5190
2023
Q3 		$3.76K Buy
11,940
+4,612
+63% +$3.2K ﹤0.01% 4957
2023
Q2 		$6.78K Buy
7,328
+2,695
+58% +$1.94K ﹤0.01% 4661
2023
Q1 		$4K Buy
4,633
+1,175
+34% +$1.52K ﹤0.01% 5142
2022
Q4 		$6K Sell
3,458
-1,791
-34% -$3.95K ﹤0.01% 4800
2022
Q3 		$11K Buy
5,249
+4,272
+437% +$8.54K ﹤0.01% 4490
2022
Q2 		$3K Buy
977
+837
+598% +$2.68K ﹤0.01% 5445
2022
Q1 		$1K Buy
+140
New +$585 ﹤0.01% 5921
2021
Q3 		– Sell
-2,035
Closed -$21K – 6317
2021
Q2 		$21K Sell
2,035
-86
-4% -$821 ﹤0.01% 3863
2021
Q1 		$16K Sell
2,121
-692
-25% -$4.58K ﹤0.01% 4075
2020
Q4 		$11K Sell
2,813
-3,864
-58% -$14.9K ﹤0.01% 4272
2020
Q3 		$24K Buy
6,677
+3,928
+143% +$22.9K ﹤0.01% 3808
2020
Q2 		$25K Buy
+2,749
New +$19.6K ﹤0.01% 3572

Other funds holding NMRD

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Tower Research Capital (TRC)'s NMRD Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 11,872 shares — an estimated $2.6K sold.

Tower Research Capital (TRC) first reported a position in NMRD in Q2 2020 and held it in 13 quarters. The position peaked at $25K in Q2 2020. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 11,872 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $2.6K.
  • Tower Research Capital (TRC) first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Nemaura Medical, Inc. Common Stock position peaked at $25K in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.